Oric Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
Oric Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Oric Pharmaceuticals | DEFA14A: Others
Oric Pharmaceuticals | DEF 14A: Definitive proxy statements
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
Oric Pharmaceuticals | 8-K: Current report
Oric Pharmaceuticals | 8-K: Current report
No Data